Rémy Slama (PhD) is Senior Investigator at Inserm (the French Institute of Health and Medical Research, the main research institution dedicated to biomedical research in the EU) where he leads the Inserm-Grenoble-Alpes University joint research team in Environmental Epidemiology applied to Reproduction and Respiratory Health. Since 2020, he is also chair of Inserm Public Health Thematic Institute overseeing all Inserm public health teams.

His research aims at characterizing the influence of environmental contaminants on human reproduction and childhood health. A specific focus is the influence of early life (intra-uterine) environmental exposures on the health of the fetus and the child (Developmental Origins of Health and Diseases, or DOHaD, concept). In that context, his team is particularly interested in the effects of atmospheric pollutants, short half-lived endocrine disruptors (phenols, phthalates) and, more recently, the exposome as a whole. His methodological research track focuses on approaches to limit exposure misclassification (such as the within-subject biospecimens pooling approach) and on study design. He has led the statistical work package of HELIX (EU) early-life exposome project and is co-PI of ATHLETE (EU H2020) ATHLETE exposome project. He published over 170 scientific articles.
R. Slama is a former member of the EU SCHEER (Scientific Committee for Emerging and Environmental Risks), president of the scientific council of the French research program on endocrine disruptors (PNRPE); he belongs to several experts groups and scientific councils related to environmental health. He received the Tony McMichael award from the International Society of Environmental Epidemiology (ISEE) and co-authored with Pr. Demeneix a report on “Endocrine Disruptors: from Scientific Evidence to Human Health Protection” for the EU Parliament (2019).